The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study. (21st December 2021) - Badawy, Sherif M.; Kattamis, Antonis; Ezzat, Hatoon; Deschamps, Benoît; Sicard, Eric; Fradette, Caroline; Zhao, Feng; Tricta, Fernando; Chung Tsang, Yu; Sheth, Sujit; Piga, Antonio